A meta-analysis found that patients with early and intermediate-stage hepatocellular carcinoma who received external beam radiation therapy (EBRT) demonstrated better local control and progression ...

EBRT with or without STAD showed similar 15-year PCSS and OS rates in IRPC patients, with high PSA failure rates observed. Multivariate analysis indicated greater side effects in the STAD group ...

Patients in the EBRT study arm were treated with a radiation dose of either 68 Gy (n = 58) a low dose by today's standards, or ≥70 Gy (n = 56); elective nodal radiotherapy was not used.